SU Group Wins US$2.4 Million Follow-on Award, Expanding Landmark Smart-Hospital Project to US$13.7 Million
Additional Award Broadens the Company's Role in Mission-Critical Healthcare Infrastructure and Strengthens Revenue Visibility HONG KONG, Aug. 26, 2026 /PRNewswire/ -- SU Group Holdings Limited (Nasdaq: SUGP) ("SU Group" or the "Company"), an integrated security-related engineering services company in Hong Kong, today announced that it has secured a follow-on award valued...
PENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy Worldwide
Expanded agreement combines PENTAX Medical's continued investment in flexible reusable endoscopy with MAGENTIQ's clinically validated AI capabilities, expanding access to AI-assisted colonoscopy across USA, EMEA, JAPAC and LATAM. TOKYO, Aug. 26, 2026 /PRNewswire/ -- PENTAX Medical, a HOYA Group company, today announced the expansion of its partnership with MAGENTIQ EYE, extending an agreement that initially covered the United...
From Strategy to Value: Neutech’s 2026 Interim Results Confirm the Growth Logic of Its “Education-Healthcare-Wellness” Ecosystem
HONG KONG and DALIAN, China, Aug. 26, 2026 /PRNewswire/ -- On 26 August 2026, Neutech Group Limited (Stock Code: 9616.HK) released its interim results. For the first half of 2026, the Group firmly implemented its core strategy of "education-healthcare-wellness", continued to deepen business deployment, and delivered steady improvement in overall performance. During the Reporting Period, the Group recorded...
Alebund Pharmaceuticals Announces 2026 Interim Results
SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its unaudited consolidated interim results for the six months ended June 30, 2026 (the "Reporting Period"). During the Reporting Period and up to the date of the interim results announcement, the Company made significant progress...
SynbioTech to Present TWK10® Research and Microbiome CDMO Platform in the Emerging GLP-1 Companion-Nutrition Market at Vitafoods Asia 2026
Backed by gut-muscle axis research, 27 scientific publications and multi-market readiness, TWK10® beyond appetite control. KAOHSIUNG, Aug. 26, 2026 /PRNewswire/ -- As GLP-1-based therapies reshape weight management, brands are looking beyond appetite control to nutrition quality, protein utilization, muscle support and long-term vitality. Nutrition conversations increasingly connect to women's healthy aging and active living. SynbioTech, the world-leading biotechnology...
China’s BCI Race Accelerates: Gestala Raises US$84 Million in Six Months
SHANGHAI and CHENGDU, China, Aug. 26, 2026 /PRNewswire/ -- Gestala officially launched on January 1, 2026. Six months later, the company had completed two financing rounds totaling RMB 570 million, or approximately US$84 million. The financing reflects growing investor interest in alternatives to implantable electrode-based BCIs—particularly approaches that aim to cover...
Caliway’s CBL-514 Combination Therapy Cleared by U.S. FDA for Phase 2 Trial; Pivotal Phase 3 Trial SUPREME-01 Initiates Enrollment
FDA IND Clearance for CBL-0201WR—Caliway has cleared its Investigational New Drug application for CBL-0201WR, a Phase 2 trial evaluating CBL-514 in combination with tirzepatide. U.S. IRB Approval for Pivotal Phase 3 Trial SUPREME-01 (CBL-0301)—The protocol amendment for the pivotal Phase 3 clinical trial SUPREME-01 has been approved by the North...
HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCAR™ T-Cell
KEY POINTS First patient safely dosed in Phase 1 KOALA trial evaluating KMCAR™ T-cell therapy in patients with relapsed/refractory kappa-restricted multiple myeloma Patient was monitored after initial dose to assess response and side-effects, with the treatment seen as well tolerated, and second patient to be treated imminently The study is the first in-human trial for the novel...
MINISH USA Highlights a Tooth-Preserving Approach Amid Growing Conversations Around Cosmetic Dentistry
MINISH USA highlights a restorative approach centered on preserving natural tooth structure. LOS ANGELES, Aug. 26, 2026 /PRNewswire/ -- Conversations around cosmetic dentistry are evolving as patients become more informed about treatment options, tooth preparation, and long-term outcomes. Recent social media and consumer discussions reflect growing interest in how aesthetic dental treatment may affect natural teeth over time....
Metabolon Completes Landmark Global Health Pilot Advancing Women’s and Infant Health
Innovative sample collection methods developed through Gates Foundation-funded grant enable high-quality metabolomics biomarker discovery in populations from low- and middle-income countries MORRISVILLE, N.C., Aug. 25, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in metabolomics solutions advancing life science research, diagnostics, therapeutics, and precision medicine, today announced the successful completion of...
